Lyophilized Symbiotic Mitigates Mucositis Induced by 5-Fluorouracil

• Main Authors: Bruna Savassi (Author), Bárbara F. Cordeiro (Author), Sara H. Silva (Author), Emiliano R. Oliveira (Author), Giovanna Belo (Author), Alessandra Gomes Figueiroa (Author), Maria Izabel Alves Queiroz (Author), Ana Maria Caetano Faria (Author), Juliana Alves (Author), Tales Fernando da Silva (Author), Gabriela Munis Campos (Author), Erick A. Esmerino (Author), Ramon S. Rocha (Author), Monica Q. Freitas (Author), Marcia C. Silva (Author), Adriano G. Cruz (Author), Kátia Duarte Vital (Author), Simone O.A. Fernandes (Author), Valbert N. Cardoso (Author), Leonardo Borges Acurcio (Author), Gwénaël Jan (Author), Yves Le Loir (Author), Alfonso Gala-Garcia (Author), Fillipe Luiz R. do Carmo (Author), Vasco Azevedo (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Mucositis is an adverse effect of cancer chemotherapies using 5-Fluorouracil (5-FU). It is characterized by mucosal inflammation, pain, diarrhea, and weight loss. Some studies reported promising healing effects of probiotic strains, when associated with prebiotics, as adjuvant treatment of mucositis...